Aims: In this first multicentre study we assessed the safety and efficacy of percutaneous transendocardial skeletal myoblast injection as a stand alone procedure in congestive heart failure patients.
1. Department of Cardiology, Thorax Center, Erasmus Medical Center, Rotterdam, The Netherlands (PCS, DAMJT, EB, EEMO, MV, PWS); 2. Department of Cardiology, Universitätsklinikum Rostock, Rostock, Germany (CN, HI); 3. Department of Cardiology, Centre Cuore
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
myogenesisskeletal myoblastsheart failurecell transplantationpercutaneous